Embla Medical hf. (CPH: EMBLA)

Embla Medical Income Statement

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Sep 30, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Revenue	840.31	785.68	718.65	718.67	629.5	686.26
Revenue Growth (YoY)	9.64%	9.33%	-0.00%	14.16%	-8.27%	11.97%
Cost of Revenue	319.17	300.11	278.9	263.28	238.27	247.61
Gross Profit	521.13	485.57	439.75	455.39	391.24	438.65
Selling, General & Admin	375.07	359.97	338.59	328.03	306.95	308.1
Research & Development	39.94	38.14	34.02	31.74	31.02	31.33
Operating Expenses	415	398.11	372.61	359.76	337.97	339.42
Operating Income	106.13	87.46	67.14	95.62	53.27	99.23
Interest Expense	-21.26	-17.96	-11.2	-9.8	-9.61	-8.33
Interest & Investment Income	2.18	3.45	0.78	0.17	0.46	1.02
Earnings From Equity Investments	5.08	3.4	0.36	0.4	0.29	0.26
Currency Exchange Gain (Loss)	-0.47	-0.67	2.61	1.12	-5.88	1.27
Other Non Operating Income (Expenses)	-0.81	0.33	-3.51	-0.87	-3.86	-1.47
EBT Excluding Unusual Items	90.85	76.01	56.17	86.64	34.66	91.97
Merger & Restructuring Charges	-1	-	-	-	-	-1.7
Impairment of Goodwill	-	-	-	-	-5.25	-
Gain (Loss) on Sale of Assets	-	-	-	-	-5.37	-
Asset Writedown	-	-	-	-	-11.33	-
Pretax Income	89.85	76.01	56.17	86.64	12.72	90.27
Income Tax Expense	20.49	17.21	12.96	20.98	4.8	21.4
Earnings From Continuing Operations	69.36	58.8	43.21	65.66	7.92	68.87
Minority Interest in Earnings	-0.29	-0.41	-0.7	-1.66	-1.71	-2.83
Net Income	69.07	58.39	42.51	63.99	6.21	66.04
Net Income to Common	69.07	58.39	42.51	63.99	6.21	66.04
Net Income Growth	32.06%	37.34%	-33.57%	929.84%	-90.59%	-17.20%
Shares Outstanding (Basic)	428	420	418	422	422	423
Shares Outstanding (Diluted)	428	420	418	423	423	425
Shares Change (YoY)	0.69%	0.60%	-1.17%	0.02%	-0.43%	-0.45%
EPS (Basic)	0.16	0.14	0.10	0.15	0.01	0.16
EPS (Diluted)	0.16	0.14	0.10	0.15	0.01	0.16
EPS Growth	31.16%	36.53%	-32.78%	929.72%	-90.55%	-16.82%
Free Cash Flow	91.51	65.09	44.22	83.57	78.47	75.39
Free Cash Flow Per Share	0.21	0.15	0.11	0.20	0.19	0.18
Dividend Per Share	-	-	-	-	-	0.023
Dividend Growth	-	-	-	-	-	4.91%
Gross Margin	62.02%	61.80%	61.19%	63.37%	62.15%	63.92%
Operating Margin	12.63%	11.13%	9.34%	13.31%	8.46%	14.46%
Profit Margin	8.22%	7.43%	5.92%	8.90%	0.99%	9.62%
Free Cash Flow Margin	10.89%	8.28%	6.15%	11.63%	12.47%	10.99%
EBITDA	124.51	108.29	89.45	119.86	77.01	120.92
EBITDA Margin	14.82%	13.78%	12.45%	16.68%	12.23%	17.62%
D&A For EBITDA	18.38	20.83	22.31	24.23	23.75	21.7
EBIT	106.13	87.46	67.14	95.62	53.27	99.23
EBIT Margin	12.63%	11.13%	9.34%	13.31%	8.46%	14.46%
Effective Tax Rate	22.81%	22.64%	23.08%	24.22%	37.73%	23.70%

Source: S&P Capital IQ. Standard template. Financial Sources.